DE69231586D1 - Pharmazeutische anwendungen auf der basis von peptid-metall-ionen - Google Patents
Pharmazeutische anwendungen auf der basis von peptid-metall-ionenInfo
- Publication number
- DE69231586D1 DE69231586D1 DE69231586T DE69231586T DE69231586D1 DE 69231586 D1 DE69231586 D1 DE 69231586D1 DE 69231586 T DE69231586 T DE 69231586T DE 69231586 T DE69231586 T DE 69231586T DE 69231586 D1 DE69231586 D1 DE 69231586D1
- Authority
- DE
- Germany
- Prior art keywords
- metal ions
- useful metal
- medically useful
- applications based
- pharmaceutical applications
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/816,476 US5346687A (en) | 1989-08-09 | 1992-01-03 | Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging |
US07/816,477 US5460785A (en) | 1989-08-09 | 1992-01-03 | Direct labeling of antibodies and other protein with metal ions |
US07/840,077 US5443816A (en) | 1990-08-08 | 1992-02-20 | Peptide-metal ion pharmaceutical preparation and method |
US07/998,910 US5556609A (en) | 1992-02-20 | 1992-12-30 | YIGSR peptide radiopharmaceutical applications |
US07/998,820 US5738838A (en) | 1992-02-20 | 1992-12-30 | IKVAV peptide radiopharmaceutical applications |
PCT/US1992/011334 WO1993012819A1 (en) | 1992-01-03 | 1992-12-31 | Protein- and peptide-metal ion pharmaceutical applications |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231586D1 true DE69231586D1 (de) | 2001-01-04 |
DE69231586T2 DE69231586T2 (de) | 2001-07-19 |
Family
ID=27542230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231586T Revoked DE69231586T2 (de) | 1992-01-03 | 1992-12-31 | Pharmazeutische anwendungen auf der basis von peptid-metall-ionen |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0629133B1 (de) |
AT (1) | ATE197767T1 (de) |
AU (1) | AU683833B2 (de) |
CA (1) | CA2127284C (de) |
DE (1) | DE69231586T2 (de) |
DK (1) | DK0629133T3 (de) |
ES (1) | ES2155447T3 (de) |
WO (1) | WO1993012819A1 (de) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792444A (en) * | 1989-05-09 | 1998-08-11 | The General Hospital Corporation | Labeled chemotactic peptides to image focal sites of infection or inflammation |
US5443816A (en) * | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US7238340B1 (en) * | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
US5849261A (en) * | 1991-02-08 | 1998-12-15 | Diatide, Inc. | Radiolabeled vasoactive intestinal peptides for diagnosis and therapy |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5738838A (en) * | 1992-02-20 | 1998-04-14 | Rhomed Incorporated | IKVAV peptide radiopharmaceutical applications |
US5556609A (en) * | 1992-02-20 | 1996-09-17 | Rhomed Incorporated | YIGSR peptide radiopharmaceutical applications |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
US5440015A (en) * | 1992-07-21 | 1995-08-08 | Glycomed Incorporated | Selectin peptide medicaments for treating disease |
DE4301871A1 (de) * | 1993-01-13 | 1994-07-14 | Diagnostikforschung Inst | Neue Mittel zur Diagnose von Gefäßerkrankungen |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
ATE199089T1 (de) * | 1993-06-23 | 2001-02-15 | Diatide Inc | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung |
PT772459E (pt) * | 1994-05-02 | 2003-06-30 | Diatide Inc | Agentes de imagem marcados tecnecio-99m |
US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
DE4425778A1 (de) * | 1994-07-13 | 1996-01-18 | Diagnostikforschung Inst | Komplexverbindungen zur Diagnose von Gefäßerkrankungen |
US5662885A (en) * | 1994-07-22 | 1997-09-02 | Resolution Pharmaceuticals Inc. | Peptide derived radionuclide chelators |
US6027711A (en) * | 1995-06-07 | 2000-02-22 | Rhomed Incorporated | Structurally determined metallo-constructs and applications |
ATE246009T1 (de) * | 1995-06-07 | 2003-08-15 | Immunomedics Inc | Thiolierung von peptiden zur strahlendiagnostik und strahlentherapie auf radionuklidbasis |
JP3565351B2 (ja) | 1996-05-15 | 2004-09-15 | アルタレックス メディカル コーポレイション | 免疫応答を惹起するための、多数エピトープ含有抗原の再構成法および組成物 |
US8038994B2 (en) | 1996-05-15 | 2011-10-18 | Quest Pharmatech Inc. | Combination therapy for treating disease |
US6106804A (en) * | 1997-06-13 | 2000-08-22 | The University Of New Mexico | Arsenic-72 labeled compounds for tissue specific medical imaging |
US7060251B1 (en) | 1997-09-08 | 2006-06-13 | The General Hospital Corporation | Imaging agents for early detection and monitoring of cardiovascular plaque |
EP2324857A1 (de) * | 1997-09-08 | 2011-05-25 | The General Hospital Corporation | Vorbereitung zur schnelle Bilddarstellung von cardiovaskulare Erkrankungen |
ATE384075T1 (de) * | 1998-05-15 | 2008-02-15 | Ge Healthcare Ltd | Markierte glutamin- und lysinanaloge |
US6254852B1 (en) | 1999-07-16 | 2001-07-03 | Dupont Pharmaceuticals Company | Porous inorganic targeted ultrasound contrast agents |
US6685914B1 (en) | 1999-09-13 | 2004-02-03 | Bristol-Myers Squibb Pharma Company | Macrocyclic chelants for metallopharmaceuticals |
MXPA04000173A (es) | 2001-07-10 | 2004-03-18 | Amersham Health As | Compuestos basados en peptidos. |
US20030026764A1 (en) * | 2001-07-31 | 2003-02-06 | Immunomedics, Inc. | Polymeric delivery systems |
US7317104B2 (en) | 2003-06-13 | 2008-01-08 | Bristol-Myers Squibb Pharma Company | Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
US7319149B2 (en) | 2003-06-13 | 2008-01-15 | Bristol-Myers Squibb Pharma Company | Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
US7371364B2 (en) | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
JP5469794B2 (ja) | 2003-09-08 | 2014-04-16 | プロポーショナル テクノロジーズ,インコーポレイテッド | 放射線標識されたCu−ビス(チオセミカルバゾン)錯体を容易に調合して、医療現場における62Cuキット製剤の高濃度輸送をするための小型62Zn/62Cu生成装置 |
ATE447417T1 (de) | 2004-03-04 | 2009-11-15 | Ge Healthcare As | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie |
US7439012B2 (en) | 2004-08-17 | 2008-10-21 | Wake Forest University Health Sciences | Ambient stored blood plasma expanders containing keratose |
US8920827B2 (en) | 2005-10-21 | 2014-12-30 | Wake Forest University Health Sciences | Keratin bioceramic compositions |
US7892573B2 (en) | 2006-02-10 | 2011-02-22 | Wake Forest University Health Sciences | Nerve regeneration employing keratin biomaterials |
US9149566B2 (en) | 2006-02-17 | 2015-10-06 | Wake Forest University Health Sciences | Coatings and biomedical implants formed from keratin biomaterials |
US8273702B2 (en) | 2006-02-17 | 2012-09-25 | Wake Forest University Health Sciences | Wound healing compositions containing keratin biomaterials |
FR2940077B1 (fr) | 2008-12-19 | 2012-07-20 | Oreal | Procede de coloration eclaircissante de matieres keratiniques mettant en oeuvre une composition anhydre colorante comprenant un agent alcalin et une composition oxydante. |
EP2198831B1 (de) | 2008-12-19 | 2017-05-10 | L'Oréal | Verfahren zur Aufhellung, aufhellenden Direktfärbung oder Oxidationsfärbung in Gegenwart von organischen Aminen und Mineralbasen, sowie Kit |
EP2198834B1 (de) | 2008-12-19 | 2015-03-18 | L'Oréal | Aufhellungsverfahren für menschliche Keratinfasern durch Einsatz einer wasserfreien Zusammensetzung und einer basischen Mischung aus Monoethanolamin und Aminsäure, sowie geeignete Vorrichtung |
JP5808521B2 (ja) | 2008-12-19 | 2015-11-10 | ロレアル | アンモニウム塩の存在下で、淡色化し、あるいは淡色化直接染色し、あるいは酸化染色する方法、及びそのためのデバイス |
EP2198833B1 (de) | 2008-12-19 | 2017-07-26 | L'Oréal | Verfahren zur Färbung oder Aufhellung der menschlichen keratinischen Haare mit einer wasserfreien Zubereitung und einer anorganischen Base und Kit |
FR2940103B1 (fr) | 2008-12-19 | 2011-06-10 | Oreal | Procede de coloration eclaircissante de matieres keratiniques mettant en oeuvre une emulsion comprenant un colorant et un agent alcalin et une composition oxydante |
US7922777B2 (en) | 2008-12-19 | 2011-04-12 | L'ORéAL S.A. | Lightening and dyeing of human keratin fibers using an anhydrous composition comprising a monoethyanolamine/basic amino acid mixture, and device therefor |
EP2198838B1 (de) | 2008-12-19 | 2018-09-05 | L'Oréal | Verfahren und Kit zum Aufhellen oder direkten oder oxidativen Färben keratinischer Fasern mit einer wässrigen Zusammensetzung reich an Fettkörpern |
WO2010093882A1 (en) | 2009-02-13 | 2010-08-19 | Wake Forest University Health Sciences | Keratin biomaterials for cell culture and methods of use |
FR2942704B1 (fr) | 2009-03-04 | 2011-09-02 | Oreal | Dispositif de distribution d'une composition tinctoriale pour les fibres keratiniques et procede associe. |
FR2949971B1 (fr) | 2009-09-17 | 2012-08-17 | Oreal | Procede d'eclaircissement ou de coloration en presence d'une composition anhydre particuliere et dispositif |
FR2951080B1 (fr) | 2009-10-13 | 2012-01-20 | Oreal | Composition comprenant un corps gras et un acide organophosphonique ou l'un de ses sels, procede de coloration ou d'eclaircissement la mettant en oeuvre et dispositifs |
FR2954113B1 (fr) | 2009-12-22 | 2013-03-08 | Oreal | Agent de coloration et/ou de decoloration des fibres keratiniques en deux parties ou plus, sous forme d'emulsion. |
WO2011076647A2 (en) | 2009-12-22 | 2011-06-30 | L'oreal | Inverse emulsion for treating the hair comprising a particular fatty substance and an alkaline agent |
FR2954127B1 (fr) | 2009-12-22 | 2015-10-30 | Oreal | Agent de coloration et/ou de decoloration des fibres keratiniques en deux parties, comprenant un corps gras et un agent sequestrant. |
FR2954121B1 (fr) | 2009-12-22 | 2016-03-25 | Oreal | Agent de coloration et/ou de decoloration des fibres keratiniques en deux parties, comprenant un corps gras particulier et une reductone. |
WO2011076646A2 (en) | 2009-12-22 | 2011-06-30 | L'oreal | Agent for dyeing and/or bleaching keratin fibres, comprising an inverse emulsion comprising an oxidizing agent |
FR2954160B1 (fr) | 2009-12-22 | 2012-03-30 | Oreal | Composition de coloration ou d'eclaircissement comprenant un corps gras et un polymere amphotere |
FR2954101B1 (fr) | 2009-12-22 | 2012-05-11 | Oreal | Agent de coloration et/ou de decoloration des fibres keratiniques en deux parties ou plus, comprenant une composition alcaline en emulsion inverse. |
FR2954161B1 (fr) | 2009-12-23 | 2012-03-02 | Oreal | Procede de coloration ou d'eclaircissement de fibres keratiniques en presence d'alcane(s) lineaire(s) volatil(s) et dispositif |
AU2011222540B2 (en) | 2010-03-05 | 2016-09-29 | Wake Forest University Health Sciences | Controlled delivery system |
WO2011112575A1 (en) | 2010-03-08 | 2011-09-15 | Wake Forest University Health Sciences | Keratin biomaterials for treatment of ischemia |
FR2958161B1 (fr) | 2010-04-02 | 2012-04-27 | Oreal | Procede de traitement des cheveux mettant en oeuvre une emulsion directe comprenant un agent oxydant et une emulsion directe contenant un agent alcalin |
FR2959127B1 (fr) | 2010-04-22 | 2016-01-01 | Oreal | Emulsion inverse pour le traitement des cheveux comprenant un solvant particulier |
FR2960773B1 (fr) | 2010-06-03 | 2015-12-11 | Oreal | Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether |
WO2012068376A2 (en) | 2010-11-17 | 2012-05-24 | Wake Forest University Health Sciences | Keratin compositions for treatment of bone deficiency or injury |
US20140037626A1 (en) * | 2012-07-18 | 2014-02-06 | Echogen, Inc. | Metal Abstraction Peptide With Release of Metal |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO167124C (no) * | 1985-04-03 | 1991-10-09 | Du Pont Merck Pharma | Fremgangsmaate for fremstilling av et spormerket konjugat av metallthionein og biologisk aktivt molekyl. |
EP0210684A1 (de) * | 1985-07-31 | 1987-02-04 | MALLINCKRODT, INC.(a Missouri corporation) | Ein eine radioaktive Metallzusammensetzung enthaltendes Präparat für Radiodiagnostika |
ATE52516T1 (de) * | 1986-05-28 | 1990-05-15 | Mallinckrodt Inc | Technetiumchelate fuer die bestimmung der nierenfunktion. |
DE3728599A1 (de) * | 1986-12-10 | 1988-06-23 | Hoechst Ag | Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz |
ATE107862T1 (de) * | 1987-04-02 | 1994-07-15 | Centocor Inc | Methode zur markierung von antikörpern mit einem metallion. |
US5128119A (en) * | 1989-06-12 | 1992-07-07 | Immunomedics, Inc. | Methods for technetium/rhenium labeling of f(ab1)2 fragments |
US4917878A (en) * | 1988-05-02 | 1990-04-17 | Thomas Jefferson University | Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals |
AU628357B2 (en) * | 1988-05-02 | 1992-09-17 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
US5135736A (en) * | 1988-08-15 | 1992-08-04 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
US5196510A (en) * | 1988-12-29 | 1993-03-23 | Cytogen Corporation | Molecular recognition units |
NZ314680A (en) * | 1989-05-09 | 2000-08-25 | Ortho Pharma Corp | Treating localised infection or inflammation with a therapeutically conjugated chemotactic peptide |
GB8914020D0 (en) * | 1989-06-19 | 1989-08-09 | Antisoma Ltd | Synthetic peptides for use in thrombus detection |
ES2070329T3 (es) * | 1989-07-20 | 1995-06-01 | Sandoz Ltd | Derivados de polipeptidos. |
ES2125854T3 (es) * | 1989-08-09 | 1999-03-16 | Rhomed Inc | Radiomarcado directo de anticuerpos y otras proteinas con tecnetio o renio. |
US5277892A (en) * | 1990-08-08 | 1994-01-11 | Rhomed Incorporated | In vivo lymphocyte tagging |
JP2774378B2 (ja) * | 1991-02-08 | 1998-07-09 | ダイアテク,インコーポレイテッド | 映像用テクネチウム−99m標識化ポリペプチド |
-
1992
- 1992-12-31 WO PCT/US1992/011334 patent/WO1993012819A1/en active IP Right Grant
- 1992-12-31 DK DK93902846T patent/DK0629133T3/da active
- 1992-12-31 AT AT93902846T patent/ATE197767T1/de not_active IP Right Cessation
- 1992-12-31 AU AU34272/93A patent/AU683833B2/en not_active Ceased
- 1992-12-31 CA CA002127284A patent/CA2127284C/en not_active Expired - Fee Related
- 1992-12-31 EP EP93902846A patent/EP0629133B1/de not_active Revoked
- 1992-12-31 ES ES93902846T patent/ES2155447T3/es not_active Expired - Lifetime
- 1992-12-31 DE DE69231586T patent/DE69231586T2/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
ATE197767T1 (de) | 2000-12-15 |
EP0629133B1 (de) | 2000-11-29 |
AU3427293A (en) | 1993-07-28 |
DK0629133T3 (da) | 2001-04-02 |
WO1993012819A1 (en) | 1993-07-08 |
DE69231586T2 (de) | 2001-07-19 |
CA2127284A1 (en) | 1993-07-08 |
AU683833B2 (en) | 1997-11-27 |
CA2127284C (en) | 2002-02-05 |
EP0629133A1 (de) | 1994-12-21 |
ES2155447T3 (es) | 2001-05-16 |
EP0629133A4 (de) | 1995-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231586T2 (de) | Pharmazeutische anwendungen auf der basis von peptid-metall-ionen | |
ES2229045T3 (es) | Derivados de peptidos terapeuticos. | |
ES2123134T3 (es) | Peptidos biologicamente activos de dominios funcionales de la proteina bactericida aumentadora de la permeabilidad y usos de los mismos. | |
DE69535963D1 (de) | LHRH antagonistische Peptide | |
ES2072329T3 (es) | Peptidos quimiotacticos marcados para visualizar sitios de inflamacion o de infeccion. | |
DE3683368D1 (de) | Ein in der erfassung und in der identifizierung von aktivierten t-lymphozyten zu verwendendes polypeptid. | |
DE69807679T2 (de) | Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren | |
TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
DE60024092D1 (de) | Citrullin-enthaltende fibrin-derivate und ihre verwendung zur diagnose und behandlung von rheumatischer arthritis | |
DE69531004D1 (de) | p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES | |
AR006523A1 (es) | Compuestos ciclicos, inhibidores de la adhesion | |
DK0891340T3 (da) | Oxazolderivater samt fremstilling og anvendelse deraf | |
SE8901552D0 (sv) | Acid addition salts of amidated or glycine, their preparation and use | |
ES2069082T3 (es) | Derivados polimericos de farmacos biologicamente activos. | |
DE69012901D1 (de) | Hämoregulierende Peptide. | |
SE8505920D0 (sv) | New protein and its use | |
DE60033668D1 (de) | N-substituierte d-aminosäuren enthaltende peptide, zur prävention der beta-strang assoziation | |
ES2057572T3 (es) | Agentes de reconocimiento. | |
EA200001252A1 (ru) | КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА | |
IT1283899B1 (it) | Peptidi e loro usi nella terapia della malattia celiaca | |
KR930004326A (ko) | 콘드로모듈린-ii 단백질 | |
MX9206339A (es) | Nueva proteina inhibidora de trombina a partir de chinches de monte | |
ATE293598T1 (de) | Harnstoffderivate von alpha, omega-diaminosäuren und peptiden | |
DE59010852D1 (de) | Verwendung von N-(Mercaptoacyl)aminosäuren als dopaminergen und gonadotropen Arzneimitteln | |
KR950023647A (ko) | 생물학적 활성을 나타내는 폴리펩티드 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |